A number of genes (e.g., splicing factor 3b subunit 1 (SF3B1) and ten-eleven translocation- 2 (TET2)) have been identified as recurrently mutated in primary MDS patients, playing a role in the pathogenesis of the disease as driver mutations. The gene discussed is TET2; the disease is myelodysplastic syndrome.